Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
5
×
biotech
boston blog main
life sciences
national blog main
boston
boston top stories
clinical trials
deals
investing
ipo
san diego blog main
san diego top stories
san francisco blog main
startups
480 biomedical
accent therapeutics
aducanumab
akouos
alzheimer's disease
amblyotech
archive
arsenal medical
asklepios biopharmaceutical
astellas pharmaceuticals
bioeurope
biogen
biomarin pharmaceutical
biotech ipos
bob langer
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
california institute for biomedical research
cancer
cara therapeutics
chronic rhinosinusitis
coronavirus
covid-19
What
developing
5
×
ipo
drug
fda
medicines
therapeutics
company
covid
million
new
raised
treat
activity
administration
affects
americans
approvals
approved
authorized
authorizes
bio
biogen
biotech
booster
brings
clamped
date
debut
delays
disorders
dyne
dyne’s
economic
fast
food
frequency
genetic
greater
hearing
including
Language
unset
5
×
Current search:
developing
×
fda
×
unset
×
@slashgear.com
2 years ago
FDA authorizes COVID-19 booster shot, but only for some people
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
